§ Mr. Barron
To ask the Secretary of State for Health how many companies within the pharmaceutical price regulation scheme received each rate of return; how many exceeded their targets; and how many failed to reach their targets for each of the last three years for which figures are available. 
§ Mr. Malone
This information is not available for reasons of commercial confidentiality. The Department last month published a first report to Parliament on the pharmaceutical price regulation scheme, which provides an overall assessment of the operation of the scheme. Copies of the report are available in the Library.